Viewing Study NCT00002105


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2025-12-26 @ 2:00 AM
Study NCT ID: NCT00002105
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Sponsor: Sequus Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module